ABSTRACTS OF DECISIONS
DECISION OF A DELEGATE OF THE COMMISSIONER OF PATENTS
Application : No. 777324 in the name of G.J CONSULTANTS PTY LTD
Title: Isoflavone Metabolites
Action: Request for an extension of time to serve evidence in reply by NOVOGEN RESEARCH PTY LTD and an objection thereto by G.J CONSULTANTS PTY LTD
Decision: Issued 24 December 2007
Abstract
On balance, the explanation justifies an extension of time.
Furthermore, on balance the interest of the parties supports granting the extension. While it cannot be said that that there is a zero risk of prejudice to G.J Consultants Pty Ltd (GJC), there seems to be no specific disadvantage to them. The effect of not allowing the extension, thereby denying Novogen Research Pty Ltd (Novogen) the opportunity to put evidence before the Commissioner to decide who the correct owner of the patent is, would seem to outweigh any delay.
In addition, the public interest supports an extension of time. Extending the time to allow the filing of evidence that addresses the inconsistencies in evidence should lead to a more correct and just decision. In further support are Dr Heisey’s repeated assertions (on behalf of Novogen) during the hearing that he fully expected the evidence in reply to be completed within the extension requested, and that Novogen appears to have taken into account the effects of the December holiday period when requesting the present extension.
Taking all relevant considerations into account, I allow the requested extension of time to file evidence in reply until 31 December 2007.
I award costs against GJC.
PATENTS ACT 1990
DECISION OF A DELEGATE OF THE COMMISSIONER OF PATENTS
Re:Patent Application No. 777324 by G.J CONSULTANTS PTY LTD and a request for an extension of time to serve evidence in reply by Novogen Research Pty Ltd and an objection thereto by G.J Consultants Pty Ltd
BACKGROUND
Patent application 777324 in the name of G.J. Consultants Pty Ltd (GJC) was filed on 1 May 2000 as PCT/AU00/00392, for an invention titled "Isoflavone Metabolites". The application was advertised as accepted on 14 October 2004. On 14 January 2005, Novogen Research Pty Ltd (Novogen) filed a Notice of Opposition. A Statement of Grounds and Particulars followed on 14 April 2005 and partial Evidence in Support was served on 18 October 2005 following 2 extensions of time and a Notice of Production issued by Novogen on 29 July 2005 on GJC. On 18 October 2005 Novogen also filed a request pursuant to section 32 asking the Commissioner to determine the person who may proceed with the application. On the same day Novogen also filed a request for certification of a Notice of Production to be served upon themselves (i.e. Novogen) for certain agreements between GJC and Novogen. This request was accompanied by a request that the agreements be not open to public inspection pursuant to Regulation 4.3(2)(b). These agreements were produced on 31 October 2005 and were not made open to public inspection. The remaining Evidence in Support was…
Keep reading for free
Create a free CaseChat account to read G.J. Consultants Pty Ltd v Novogen Research Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2007] APO 40
- Decision Date
CaseChat Overview and Summary
Background
Background to the litigation
The matter came before a Delegate of the Commissioner of Patents for a decision on the request for an extension of time to file Evidence in Reply. Novogen Research Pty Ltd, represented by Dr Ross Heisey, filed a request for an extension of time to 31 December 2007, which G.J. Consultants Pty Ltd opposed. The application for an extension of time was heard on 23 November 2007 in Canberra. G.J. Consultants Pty Ltd filed written submissions in support of its objection, while Novogen filed written submissions and was represented by Dr Heisey.
Decision
Reasons for decision
1. Whether the explanation justifies an extension of time to file Evidence in Reply.
2. Whether the interests of the parties support granting the extension of time.
3. Whether the public interest supports an extension of time to file Evidence in Reply.
Held
1. Whether the explanation justifies an extension of time to file Evidence in Reply.
The explanation justifies an extension of time.
2. Whether the interests of the parties support granting the extension of time.
The interests of the parties support granting the extension of time.
3. Whether the public interest supports an extension of time to file Evidence in Reply.
The public interest supports an extension of time to file Evidence in Reply.
Ratio Decidendi
Legal Principle Established
This case involved a request for an extension of time to file Evidence in Reply in opposition proceedings concerning a patent application. The applicant, G.J. Consultants Pty Ltd (GJC), opposed the request, arguing that the reasons provided for the delay were insufficient and that the extension would prejudice their interests. The opponent, Novogen Research Pty Ltd, argued that the extension was necessary to address inconsistencies in the evidence and to ensure a fair and just outcome for both parties. The Delegate of the Commissioner of Patents considered the explanation for the delay, the interests of the parties, and the public interest in determining whether to grant the extension.
The Delegate found that, on balance, the explanation for the delay justified an extension of time. Novogen's expert witness was unavailable due to a matter before the Federal Court, and the complexity and volume of the evidence in answer made it difficult to prepare the evidence in reply. Although the Delegate questioned whether the delay was foreseeable and whether the December holiday period would affect the preparation of the evidence, they accepted Novogen's assurance that the evidence would be completed within the requested extension.
The Delegate also found that the interests of the parties supported granting the extension of time. Although GJC argued that the extension would increase their costs and that Novogen could apply for revocation if they were concerned about the validity of the patent, the Delegate found that denying the extension would prevent Novogen from presenting evidence to determine the correct owner of the patent. The Delegate concluded that the effect of not allowing the extension outweighed any delay to GJC.
Finally, the Delegate found that the public interest supported an extension of time. The Delegate noted that extending the time to allow the filing of evidence that addresses the inconsistencies in evidence should lead to a more correct and just decision. The Delegate was also reassured by Novogen's confidence that the evidence would be completed within the extension requested, even taking into account the December holiday period.
Taking all relevant considerations into account, the Delegate allowed the requested extension of time to file Evidence in Reply until 31 December 2007. The Delegate awarded costs against GJC.